384 THE (HINA STUDY
- Cairns]. "The treatment of diseases and the War against Cancer." Sci. Am. 253 (1985):
31-39. - CuzickJ, and Baum M. "Tamoxifen and contralateral breast cancer." Lancet 2 (1985): 282.
- CuzickJ, Wang DY, and Bulbrook RD. "The prevention of breast cancer." Lancet 1 (1986):
83-86. - Fisher B, Costantino JP, Wickerham DL, et a!. "Tamoxifen for prevention of breast cancer:
report of the National Surgical Adjuvant Breast and Bowel Project P-l Study" j. Nat. Cancer
Inst. 90 (1998): 1371-1388. - Freedman AN, Graubard BI, Rao SR, et a!. "Estimates of the number of U.S. women who
could benefit from tamoxifen for breast cancer chemoprevention." j. Nat. Cancer Inst. 95
(2003): 526--532. - Powles T, Eeles R, Ashley S, et a!. "Interim analysis of the incidence of breast cancer in the
Royal Marsden Hospital tamoxifen randomised chemoprevention tria!''' Lancet 352 (1998):
98-101. - Veronesi U, Maisonneuve P, Costa A, et a!. "Prevention of breast cancer with tamoxifen: pre-
liminary findings from the Italian randomised trial among hysterectomised women." Lancet
352 (1998): 93-97. - CuzickJ. "A brief review of the current breast cancer prevention trials and proposals for
future trials." Eur J Cancer 36 (2000): 1298-1302. - Cummings SR, Eckert S, Krueger KA, et a!. "The effect of raloxifene on risk of breast cancer
in postmenopausal women: results from the MORE randomized tria!." JAMA 281 (1999):
2189-2197. - Dorgan JF, Hunsberger S, A., McMahon RP, et a!. "Diet and sex hormones in girls: findings
from a randomized controlled clinical tria!''' j. Nat. Cancer Inst. 95 (2003): 132-141. - Ornish D, Scherwitz LW, BillingsJH, et a!. "Intensive lifestyle changes for reversal of coronary
heart disease." JAMA 280 (1998): 2001-2007. - Esseistyn CB, Ellis SG, Medendorp Sv, et a!. "A strategy to arrest and reverse coronary artery
disease: a 5-year longitudinal study of a single physician's practice." j. Family Practice 41
(1995): 560-568. - Hildenbrand GLG, Hildenbrand LC, Bradford K, et a!. "Five-year survival rates of melanoma
patients treated by diet therapy after the manner of Gerson: a retrospective review." Alterna-
tive Therapies in Health and Medicine 1 (1995): 29-37. - Youngman LD, and Campbell TC. "Inhibition of aflatoxin Bl-induced gamma-glutamyl
transpeptidase positive (GGT+) hepatic preneoplastic foci and tumors by low protein diets:
evidence that altered GGT+ foci indicate neoplastic potentia!." Carcinogenesis 13 (1992):
1607-1613. - Ronai Z, Gradia S, El-Bayoumy K, et a!. "Contrasting incidence of ras mutations in rat mam-
mary and mouse skin tumors induced by anti-benzo!clphenanthrene-3,4-diol-l,2-epoxide."
Carcinogensis 15 (1994): 2113-2116. - Jeffy BD, Schultz EU, Selmin 0, et a!. "Inhibition of BRCA-l expression by benzo!alpyrene
and diol epoxide." Mol. Carcinogenesis 26 (1999): 100-118. - Gammon MD, Santella RM, Neugut AI, et a!. "Environmental toxins and breast cancer on
Long Island.!. Polycyclic aromatic hydrocarbon DNA adducts." Cancer Epidemiol Biomarkers
Prev 11 (2002): 677-685. - Gammon MD, Wolff MS, Neugut AI, et a!. "Environmental toxins and breast cancer on Long
Island. II. Organchlorine compound levels in blood." Cancer Epidemiol Biomarkers Prev 11
(2002): 686-697. - Humphries KH, and Gill S. "Risks and benefits of hormone replacement therapy: the evi-
dence speaks." Canadian Med. Assoc. Joum. 168 (2003): 1001-1010. - Writing Group for the Women's Health Initiative Investigators. "Risks and benefits of estro-